CINRYZE

Google image searchProduct monograph

Active ingredient

c1 esterase inhibitor (human), 500 UNIT/VIAL

DIN: 02395371

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIALS

Schedule: Schedule D

Company: TAKEDA CANADA INC

Date: 08-JUN-2021

ATC:

• B06 — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD, )
• B06A — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD)
• B06AC — Drugs used in hereditary angioedema (ATC, ATC/DDD)
• B06AC01 — C1-INHIBITOR, PLASMA DERIVED (ATC/DDD)

Reference brand drug: Berinert, Cinryze, Haegarda

External Links for Cinryze

Search on Google

• Cinryze side effects
• Cinryze dosage
• c1 esterase inhibitor side effects
• c1 esterase inhibitor dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find cinryze photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.